Phenotypic Transformation Mechanisms and Therapeutic Targets of Microglia in Alzheimer's Disease
DOI:
https://doi.org/10.54097/3mhjph57Keywords:
Alzheimer's Disease, Microglia, Phenotypic Transformation, Therapeutic TargetsAbstract
The aim of this paper is to summarize the mechanism of phenotypic transformation of microglia and to explore the impact of pathological changes in Alzheimer's disease (AD) on its phenotypic regulation, with a view to providing new targets for the treatment of the disease. Recent studies have shown that microglia phenotype is highly dynamic, continuous and plastic, breaking through the limitations of the traditional M1/M2 dichotomy and laying the foundation for a deeper understanding of the AD process. By reviewing the literature related to therapeutic targets of recent hotspot studies, this paper proposes that modulation of microglia phenotype can delay the progression of AD, which provides a possible direction for realizing precision targeted therapy.
Downloads
References
[1] 2024 Alzheimer's disease facts and figures. (2024). Alzheimer's & dementia : the journal of the Alzheimer's Association, 20(5), 3708–3821.
[2] Zong, N. C., Zhang, Y., Huang, Y., & Cai, H. (2025). Addressing Healthy Aging: Time to Stop a Tsunami of Rising Alzheimer's Disease. Aging and disease, 10.14336/AD.2024.1476. Advance online publication.
[3] Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q. (2022). Alzheimer's Disease: Epidemiology and Clinical Progression. Neurology and therapy, 11(2), 553–569.
[4] Dulewicz, M., Kulczyńska-Przybik, A., Mroczko, P., Kornhuber, J., Lewczuk, P., & Mroczko, B. (2022). Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria. International journal of molecular sciences, 23(15), 8598.
[5] He, C., Chen, B., Yang, H., & Zhou, X. (2025). The dual role of microglia in Alzheimer's disease: from immune regulation to pathological progression. Frontiers in aging neuroscience, 17, 1554398.
[6] Li, Y., Zhao, Q., Wang, Y., Du, W., Yang, R., Wu, J., & Li, Y. (2025). Lipid droplet accumulation in microglia and their potential roles. Lipids in health and disease, 24(1), 215.
[7] Brandao, W., Jain, N., Yin, Z., Kleemann, K. L., Carpenter, M., Bao, X., Serrano, J. R., Tycksen, E., Durao, A., Barry, J. L., Baufeld, C., Guneykaya, D., Zhang, X., Litvinchuk, A., Jiang, H., Rosenzweig, N., Pitts, K. M., Aronchik, M., Yahya, T., Cao, T., … Butovsky, O. (2025). Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy. Science translational medicine, 17(781), eadk3690.
[8] Zhao, W., Liu, Z., Wu, J., Liu, A., & Yan, J. (2026). Potential targets of microglia in the treatment of neurodegenerative diseases: Mechanism and therapeutic implications. Neural regeneration research, 21(4), 1497–1511.
[9] Long, J., Tian, G., He, K., Su, Y., Wang, Z., Huang, L., Yao, Y., Li, X., & Lin, Y. (2025). The role of microglia in neuropathic pain: A systematic review of animal experiments. Brain research bulletin, 228, 111410.
[10] Yang, L., Huang, H., Fan, Y., Xu, L., Jin, X., Xiao, B., Ma, C., Fan, H., & Chai, Z. (2025). Astragaloside IV ameliorates Parkinson's disease by inhibiting TLR4/NF-κB-dependent neuroinflammation. International immunopharmacology, 160, 114972.
[11] Vidal-Itriago, A., Radford, R. A. W., Aramideh, J. A., Maurel, C., Scherer, N. M., Don, E. K., Lee, A., Chung, R. S., Graeber, M. B., & Morsch, M. (2022). Microglia morphophysiological diversity and its implications for the CNS. Frontiers in immunology, 13, 997786.
[12] Martins-Ferreira, R., Calafell-Segura, J., Leal, B., Rodríguez-Ubreva, J., Martínez-Saez, E., Mereu, E., Pinho E Costa, P., Laguna, A., & Ballestar, E. (2025). The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nature communications, 16(1), 739.
[13] Depp, C., Doman, J. L., Hingerl, M., Xia, J., & Stevens, B. (2025). Microglia transcriptional states and their functional significance: Context drives diversity. Immunity, 58(5), 1052–1067.
[14] Zhang, H., Wei, W., Zhao, M., Ma, L., Jiang, X., Pei, H., Cao, Y., & Li, H. (2021). Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. International journal of biological sciences, 17(9), 2181–2192.
[15] Sinsky, J., Pichlerova, K., & Hanes, J. (2021). Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies. International journal of molecular sciences, 22(17), 9207.
[16] Fujikawa, R., & Tsuda, M. (2023). The Functions and Phenotypes of Microglia in Alzheimer's Disease. Cells, 12(8), 1207.
[17] Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022). Microglia and Alzheimer's Disease. International journal of molecular sciences, 23(21), 12990.
[18] Flury, A., Aljayousi, L., Park, H. J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., González Ibáñez, F., Braniff, O., Ngo, T., Smith, S., Velez, M., Ramirez, D. M., Avnon-Klein, D., Murray, J. W., Liu, J., Parent, M., Mingote, S., … Ayata, P. (2025). A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion. Neuron, 113(4), 554–571.e14.
[19] Martins-Ferreira, R., Calafell-Segura, J., Leal, B., Rodríguez-Ubreva, J., Martínez-Saez, E., Mereu, E., Pinho E Costa, P., Laguna, A., & Ballestar, E. (2025). The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nature communications, 16(1), 739.
[20] Lopez-Ortiz, A. O., Doceti, M., Thomas, J., Duffy, A., Coburn, M., K Okojie, A., Lee, A., Sou, E. A., Gaultier, A., & Eyo, U. B. (2025). Transcriptional Regulation of Microglial Metabolic and Activation States by P2RY12. Glia, 10.1002/glia.70078. Advance online publication.
[21] Samant, R. R., Standaert, D. G., & Harms, A. S. (2024). The emerging role of disease-associated microglia in Parkinson's disease. Frontiers in cellular neuroscience, 18, 1476461.
[22] Jung, E. S., Choi, H., & Mook-Jung, I. (2025). Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research. Molecular neurodegeneration, 20(1), 37.
[23] Li, B., Wang, S., Kerman, B., Hugo, C., Shwab, E. K., Shu, C., Chiba-Falek, O., Arvanitakis, Z., & N Yassine, H. (2025). Microglial States Are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer's Disease. Aging cell, e70189. Advance online publication.
[24] Trujillo-Estrada, L., Dávila, J. C., Sánchez-Mejias, E., Sánchez-Varo, R., Gomez-Arboledas, A., Vizuete, M., Vitorica, J., & Gutiérrez, A. (2014). Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum. Journal of Alzheimer's disease : JAD, 42(2), 521–541.
[25] Vickers, J. C., Mitew, S., Woodhouse, A., Fernandez-Martos, C. M., Kirkcaldie, M. T., Canty, A. J., McCormack, G. H., & King, A. E. (2016). Defining the earliest pathological changes of Alzheimer's disease. Current Alzheimer research, 13(3), 281–287.
[26] Jiang, Y., Yang, X., Jiang, J., & Xiao, B. (2021). Structural Designs and Mechanogating Mechanisms of the Mechanosensitive Piezo Channels. Trends in biochemical sciences, 46(6), 472–488.
[27] Hu, J., Chen, Q., Zhu, H., Hou, L., Liu, W., Yang, Q., Shen, H., Chai, G., Zhang, B., Chen, S., Cai, Z., Wu, C., Hong, F., Li, H., Chen, S., Xiao, N., Wang, Z. X., Zhang, X., Wang, B., Zhang, L., … Mo, W. (2023). Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease. Neuron, 111(1), 15–29. e8.
[28] Zhang, M., Malko, P., & Jiang, L. H. (2023). Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation. Neural regeneration research, 18(11), 2385–2386.
[29] Liu, Y., Zhang, J., Zhao, Y., Fang, F., Zhang, S., An, Q., Zhuang, J., Xu, F., & Li, F. (2025). Mechanotransduction Activates Microglia and Impairs Phagocytosis in Stiff Amyloid-β Plaques. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(30), e03389.
[30] van Olst, L., Simonton, B., Edwards, A. J., Forsyth, A. V., Boles, J., Jamshidi, P., Watson, T., Shepard, N., Krainc, T., Argue, B. M., Zhang, Z., Kuruvilla, J., Camp, L., Li, M., Xu, H., Norman, J. L., Cahan, J., Vassar, R., Chen, J., Castellani, R. J., … Gate, D. (2025). Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease. Nature medicine, 31(5), 1604–1616.
[31] Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. F. (2025). TREM2 and sTREM2 in Alzheimer's disease: from mechanisms to therapies. Molecular neurodegeneration, 20(1), 43.
[32] Li, Y., Macyczko, J. R., Liu, C. C., & Bu, G. (2022). ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease. Neurobiology of aging, 115, 20–28.
[33] Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Scannail, A. N., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., Cerit, O., Wen, H. L., Liu, L., Welch, G., Bonner, M., & Tsai, L. H. (2022). Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell stem cell, 29(8), 1197–1212.e8.
[34] Haney, M. S., Pálovics, R., Munson, C. N., Long, C., Johansson, P. K., Yip, O., Dong, W., Rawat, E., West, E., Schlachetzki, J. C. M., Tsai, A., Guldner, I. H., Lamichhane, B. S., Smith, A., Schaum, N., Calcuttawala, K., Shin, A., Wang, Y. H., Wang, C., Koutsodendris, N., … Wyss-Coray, T. (2024). APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia. Nature, 628(8006), 154–161.
[35] Stephenson, R. A., Sepulveda, J., Johnson, K. R., Lita, A., Gopalakrishnan, J., Acri, D. J., Beilina, A., Cheng, L., Yang, L. G., Root, J. T., Ward, M. E., Combs, C., Skarnes, W. C., Cookson, M. R., Shih, H. Y., Larion, M., Rebeck, G. W., & Narayan, P. S. (2025). Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4. Cell reports, 44(7), 115961.
[36] van Olst, L., Simonton, B., Edwards, A. J., Forsyth, A. V., Boles, J., Jamshidi, P., Watson, T., Shepard, N., Krainc, T., Argue, B. M., Zhang, Z., Kuruvilla, J., Camp, L., Li, M., Xu, H., Norman, J. L., Cahan, J., Vassar, R., Chen, J., Castellani, R. J., … Gate, D. (2025). Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease. Nature medicine, 31(5), 1604–1616.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
